EpCAM-Targeted Therapy for Human Hepatocellular Carcinoma

Author： Ogawa Kousuke Tanaka Shinji Matsumura Satoshi Murakata Ayano Ban Daisuke Ochiai Takanori Irie Takumi Kudo Atsushi Nakamura Noriaki Tanabe Minoru Arii Shigeki

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.21, Iss.4, 2014-04, pp. : 1314-1322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

By Thomas Melanie

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1008-1014

Springer Publishing Company

Access to resources Recommend Favorite

Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

By Arii Shigeki

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 234-234

Springer Publishing Company

Access to resources Recommend Favorite

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

By Tanaka Shinji Arii Shigeki

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 235-241

Springer Publishing Company

Access to resources Recommend Favorite

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

By Kudo Masatoshi

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 242-255

Springer Publishing Company

Access to resources Recommend Favorite

AFP Promoter Enhancer Increased Specific Expression of the Human Sodium Iodide Symporter (hNIS) for Targeted Radioiodine Therapy of Hepatocellular Carcinoma

By Ma Xiao-Juan Huang Rui Kuang An-Ren

Cancer Investigation, Vol. 27, Iss. 6, 2009-07 ,pp. : 673-681

Informa Healthcare

Access to resources Recommend Favorite